FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, 25mM HEPES w/o L-Glutamine, Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid

FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, 25mM HEPES w/o L-Glutamine, Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid

FluxMPS™ DCP-DMEMLH-QPBR1X is a Microfluidics Suitable, ultra-filtered DMEM Low Glucose + HEPES formulation engineered for microphysiological systems (MPS), organ-on-a-chip (OoC), and microfluidic tissue models. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulation: [+] HEPES (25 mM), [+] Calcium, [+] Magnesium, [+] Low Glucose | [-] L-Glutamine, [-] Sodium Pyruvate, [-] Sodium Bicarbonate, [-] Phenol Red. HEPES (25 mM, pKa 7.3 at 37°C) provides robust CO₂-independent buffering.

• Quadruple-stage sequential filtration: 0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II, reaching a 0.04 µm final pore size
• Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch, not per unit
• Low Glucose (1000 mg/L) + 25 mM HEPES buffering; formulated without L-Glutamine, Sodium Pyruvate, Sodium Bicarbonate, or Phenol Red for full researcher-defined metabolic and optical control
• HEPES (pKa 7.3 at 37°C) provides CO₂-independent pH stability, suited to open-top microfluidic chip architectures
• Manufactured under an ISO 13485:2016 quality management system with micro-batch, per-lot QC release
• Ultrapure Type 1 water (18.2 MΩ·cm) used in formulation to minimize trace-metal and organic-carbon background
• 30 verified ingredients per lot across inorganic salts, amino acids, vitamins, and other components
• Custom pH, salts, and nutrient adjustments available on request — contact support@diagnocine.com

Engineered where standard media fails

Conventional 0.22 µm–filtered media passes mycoplasma-sized organisms, subvisible particulates, and aggregates that clog microfluidic channels and corrupt sensor signals. FluxMPS™ addresses these failure modes with four-stage filtration to a 0.04 µm final pore size. HEPES buffering removes the need for a CO₂ incubator in open-top chip architectures.

Quadruple-stage filtration system

Four serial filtration stages, run as two dedicated prefilter-plus-final-filter pairs, reach a final 0.04 µm polish — delivering sub-mycoplasma-range particulate control beyond what conventional 0.22 µm-filtered media provide.

1. 1

   0.1 µm Prefiltration I

   Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge.

2. 2

   0.04 µm Final filtration I

   First 0.04 µm pass; retains sub-micron particulates and microaggregates that a 0.22 µm filter would pass.

3. 3

   0.1 µm Prefiltration II

   Second dedicated prefilter, protecting the second 0.04 µm cartridge.

4. 4

   0.04 µm Final filtration II — Polish

   Ultimate polishing filter; aseptic fill and finish in ISO Class 5 (Class 100) conditions.

Designed for next-generation cell models

FluxMPS™ DCP-DMEMLH-QPBR1X supports platforms from single-channel microfluidic chips to multi-organ body-on-a-chip systems. The 25 mM HEPES buffer makes it well suited to open-top microfluidic devices and atmospheric CO₂ environments.

Automated Bioreactors & Robotics

An optional 0.01 µm (10 nm) ultra-filtered MPS Grade variant is available on request for automated bioreactor perfusion and robotic liquid handlers.

• Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
• Valve & Sensor Protection: Reduces micro-fouling of solenoid valves and inline optical sensors
• Extended Perfusion Stability: Supports consistent nutrient delivery over weeks-long culture

Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.

Analytical release specifications

Every lot is released against the full specification matrix below. Available pack sizes: 500 mL, 1000 mL. CoA available on request: support@diagnocine.com.

Full composition (mg/L)

30 ingredients verified per lot with CAS numbers for raw-material traceability.

Manufacturing & compliance

Every FluxMPS™ product is manufactured and released under a multi-layer quality system spanning raw materials, in-process controls, and final-product testing.

How DCP-DMEMLH-QPBR1X compares

FluxMPS™ DCP-DMEMLH-QPBR1X vs. conventional 0.22 µm-filtered DMEM Low Glucose + HEPES formulations.

Comparison figures from published supplier specifications, accessed 2 September 2026. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

Frequently asked questions

Common questions about FluxMPS™ DCP-DMEMLH-QPBR1X.

Supporting literature

Key peer-reviewed publications supporting Microfluidics Suitable, ultra-filtered media in organ-on-a-chip and microfluidic research.

1. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
2. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
3. Ham RG. Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci USA. 1965;53:288–293. doi:10.1073/pnas.53.2.288
4. Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
5. Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
6. Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
7. Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
8. Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j